1filings we hold
2topics disclosed
Chemicals and pharmaceuticalsindustry
MAbased in
Across 1 filings we hold,
Hemab Therapeutics Holdings, Inc. has written down 2 of the topics we track. That places it 218 of 222 companies we hold in chemicals and pharmaceuticals, by how much we have collected.
Chemicals and pharmaceuticals
What this obligates
Every instrument in our corpus that governs something Hemab Therapeutics Holdings, Inc. has written into a
filing. Not what they said. What applies once they have said it.
NIST Cybersecurity Framework 2.078
ISO/IEC 42001:202361
ISO 27001:202242
NIST AI Risk Management Framework (AI RMF 1.0)41
ASEAN Guide on AI Governance and Ethics35
ASD Strategies to Mitigate Cyber Security Incidents29
EU AI Act15
OECD Recommendation on Artificial Intelligence (2024 Update)8
NIST SP 800-615
9 frameworks, 314 controls between them,
deduplicated across topics.
What it discloses
Tracked topics appearing in this company's filings, most frequent first.
Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.
Recent filings
| Filed | Form | Item | |
|---|
| 2026-05-21 | 10-Q | | filing |
Others in chemicals and pharmaceuticals
The companies we hold most on in the same industry. Each opens side by side with this
one.
What this page is
Every row comes from SEC full-text search over this company's filings, matched against the
compliance and risk phrases we track. It is a record of what the company itself wrote down in
documents it is legally accountable for. It is not an assessment of the company, a rating, or
a claim about how well it manages anything.
A phrase appearing in a filing frequently means the risk section
mentions it, not that an event occurred. Where an item number indicates an actual event, the
Item column says so.
All of
chemicals and pharmaceuticals · All companies ·
Today's edition